Meyler's Side Effects Of Cardiovascular Drugs

Description:
Elsevier now offers a series of derivative works based on the acclaimed 'Meyler's Side Effect of Drugs, 15th Edition'. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. Each year, heart disease kills more Americans than cancer. In the clinical setting, patients are treated by a variety of specialists and primary care practitioners, depending on the organ system involved. This volume will enable practitioners to prescribe preventative treatments with medications such as blood pressure reducers, aspirin, and cholesterol-lowering drugs, as well as drugs used for more aggressive therapy. It surpasses the 'Physician's Desk Reference' (copyright) by including clinical case studies and independent expert analysis and includes complete index of drug names. It offers most complete cross referencing of drug-drug interactions available and includes extensive references to primary and secondary literature. It also includes information on adverse effects in pregnancy. The book is divided into six sections: Drugs used to treat hypertension, heart failure and angina pectoris; Diuretics - a general introduction to their adverse effects, followed by monographs on individual drugs; Antidysrhythmic drugs - a general introduction to their adverse effects, followed by monographs on individual drugs; Drugs that act on the cerebral and peripheral circulations; Anticoagulants, thrombolytic agents, and anti-platelet drugs; and, Cardiovascular adverse effects of non-cardiovascular drugs.

Author Biography:
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is also the editor of Meyler's Side Effects of Drugs and the Side Effects of Drugs Annual series. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.